Johnson & Johnson
JNJ
#23
Rank
S$475.41 B
Marketcap
$197.59
Share price
0.03%
Change (1 day)
-0.73%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

P/E ratio for Johnson & Johnson (JNJ)

P/E ratio as of June 2025 (TTM): 16.9

According to Johnson & Johnson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.8974. At the end of 2024 the company had a P/E ratio of 24.7.

P/E ratio history for Johnson & Johnson from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202424.7127.63%
202310.9-57.98%
202225.919.85%
202121.6-23.35%
202028.233.07%
201921.2-6.74%
201822.7-92.46%
20173011460.23%
201619.34.46%
201518.52.49%
201418.0-3.32%
201318.64.62%
201217.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
16.8-0.41%๐Ÿ‡บ๐Ÿ‡ธ USA
11.3-32.84%๐Ÿ‡บ๐Ÿ‡ธ USA
18.2 7.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
17.4 2.73%๐Ÿ‡ซ๐Ÿ‡ท France
51.1 202.26%๐Ÿ‡บ๐Ÿ‡ธ USA
25.9 53.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
62.0 266.81%๐Ÿ‡บ๐Ÿ‡ธ USA
17.1 1.05%๐Ÿ‡บ๐Ÿ‡ธ USA
26.2 54.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
22.8 34.98%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.